Libra may have dominated the news so far this week — and, of course, the new cryptocurrency announced by Facebook is underpinned by blockchain.
But elsewhere, DLT continues to make inroads into tracking items as they move across supply chains. To that end, the MediLedger project debuted a new pilot program this week, billed as a cross-industry initiative that eyes using blockchain for drug supply chains.
As reported on sites such as supplychaindigital.com, the project announced the pilot program is being sponsored by the U.S. Food and Drug Administration and will help users develop an electronic system to source and trace prescription drugs as they make their way across the United States.
The activities are being coordinated by the San Francisco blockchain technology company known as Chronicled. The project itself, according to the aforementioned site, is tied to 20 companies that span pharmaceutical manufacturers, repackagers and distributors.
Matt Sample, VP of Manufacturing Operations at AmerisourceBergen, commented in a release that, “the MediLedger pilot’s strength is that it’s a cross-industry effort to explore the use of a blockchain network to enable the interoperability required by the Drug Supply Chain Security Act (DSCSA) requirements in 2023. The potential solution is especially viable because it’s open to all participants in the Pharma industry. We’ve been working with Chronicled since 2017 on solving these industry challenges, and we believe that there is potential for great improvement in the prescription drug supply chain.”
Target Targets Blockchain, Too
Blockchain also is gaining traction in retail settings, as evidenced by the news that Target has got the technology in its sights. CoinDesk reports that the retailing juggernaut has been working on blockchain since the middle of last year, and its efforts look to be tied to supply chain management as well. That initiative has been termed…